These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23055848)

  • 1. In Vitro Comparison of Physical Parameters, Enzyme Activity, Acid Resistance, and pH Dissolution Characteristics of Enteric-Coated Pancreatic Enzyme Preparations: Implications for Clinical Variability and Pharmacy Substitution.
    Kuhn RJ; Eyting S; Henniges F; Potthoff A
    J Pediatr Pharmacol Ther; 2007 Apr; 12(2):115-28. PubMed ID: 23055848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme content and acid stability of enteric-coated pancreatic enzyme products in vitro.
    Case CL; Henniges F; Barkin JS
    Pancreas; 2005 Mar; 30(2):180-3. PubMed ID: 15714141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of CREON® pancrelipase pellets via gastrostomy tube is feasible with no loss of gastric resistance or lipase activity: an in vitro study.
    Shlieout G; Koerner A; Maffert M; Forssmann K; Caras S
    Clin Drug Investig; 2011; 31(7):e1-7. PubMed ID: 21627335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro studies of microsphere pancreatic supplements.
    Littlewood JM; Kelleher J; Walters MP; Johnson AW
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S22-9. PubMed ID: 2457072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancrease gastroresistance: in vitro evaluation of pH-determined dissolution.
    Lenaerts C; Beraud N; Castaigne JP
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S18-21. PubMed ID: 3404358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment failure after substitution of generic pancrelipase capsules. Correlation with in vitro lipase activity.
    Hendeles L; Dorf A; Stecenko A; Weinberger M
    JAMA; 1990 May; 263(18):2459-61. PubMed ID: 2329633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro comparative study of three pancreatic enzyme preparations: dissolution profiles, active enzyme release and acid stability.
    Aloulou A; Puccinelli D; Sarles J; Laugier R; Leblond Y; Carrière F
    Aliment Pharmacol Ther; 2008 Feb; 27(3):283-92. PubMed ID: 17973644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro and in vivo studies of enteric-coated pancrelipase preparations for pancreatic insufficiency.
    Thomson M; Clague A; Cleghorn GJ; Shepherd RW
    J Pediatr Gastroenterol Nutr; 1993 Nov; 17(4):407-13. PubMed ID: 8145097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two enteric coated microsphere preparations in the treatment of pancreatic exocrine insufficiency caused by cystic fibrosis.
    Santini B; Antonelli M; Battistini A; Bertasi S; Collura M; Esposito I; Di Febbraro L; Ferrari R; Ferrero L; Iapichino L; Lucidi V; Manca A; Pisconti CL; Pisi G; Raia V; Romano L; Rosati P; Grazioli I; Melzi G
    Dig Liver Dis; 2000; 32(5):406-11. PubMed ID: 11030186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study.
    Graff GR; McNamara J; Royall J; Caras S; Forssmann K
    Clin Drug Investig; 2010; 30(6):351-64. PubMed ID: 20441244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
    Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of product formulation on in vitro activity of pancreatic enzymes.
    Dressman JB; Shtohryn LV; Diokno D
    Am J Hosp Pharm; 1985 Nov; 42(11):2502-6. PubMed ID: 4073069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro dissolution profiles of enteric-coated microsphere/microtablet pancreatin preparations at different pH values.
    Gan KH; Geus WP; Bakker W; Lamers CB; Heijerman HG
    Aliment Pharmacol Ther; 1996 Oct; 10(5):771-5. PubMed ID: 8899086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
    Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
    J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of effectiveness of pancreatic enzyme preparations in cystic fibrosis.
    Mischler EH; Parrell S; Farrell PM; Odell GB
    Am J Dis Child; 1982 Dec; 136(12):1060-3. PubMed ID: 7148760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis.
    Dutta SK; Hubbard VS; Appler M
    Dig Dis Sci; 1988 Oct; 33(10):1237-44. PubMed ID: 3168696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of two pancreatin microsphere preparations in cystic fibrosis.
    Elliott RB; Escobar LC; Lees HR; Akroyd RM; Reilly HC
    N Z Med J; 1992 Mar; 105(930):107-8. PubMed ID: 1553114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
    Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
    Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
    Kuhn RJ; Gelrud A; Munck A; Caras S
    Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a high lipase pancreatic enzyme extract with a regular pancreatin preparation in adult cystic fibrosis patients.
    Gan KH; Heijerman HG; Geus WP; Bakker W; Lamers CB
    Aliment Pharmacol Ther; 1994 Dec; 8(6):603-7. PubMed ID: 7696449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.